2.22
price down icon5.53%   -0.13
pre-market  시장 영업 전:  2.22  
loading
전일 마감가:
$2.35
열려 있는:
$2.31
하루 거래량:
42,913
Relative Volume:
5.05
시가총액:
$28.12M
수익:
$10.96M
순이익/손실:
$-7.02M
주가수익비율:
-3.4688
EPS:
-0.64
순현금흐름:
$-3.72M
1주 성능:
-9.57%
1개월 성능:
-28.39%
6개월 성능:
-43.08%
1년 성능:
-57.79%
1일 변동 폭
Value
$2.20
$2.375
1주일 범위
Value
$2.20
$2.49
52주 변동 폭
Value
$2.20
$6.75

Collplant Biotechnologies Ltd Stock (CLGN) Company Profile

Name
명칭
Collplant Biotechnologies Ltd
Name
전화
-
Name
주소
-
Name
직원
57
Name
트위터
@CollplantBio
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
CLGN's Discussions on Twitter

CLGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CLGN
Collplant Biotechnologies Ltd
2.22 28.12M 10.96M -7.02M -3.72M -0.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.47 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.49 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.87 36.96B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.75 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
252.77 25.74B 3.81B -644.79M -669.77M -6.24

Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-02-17 개시 Alliance Global Partners Buy

Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스

pulisher
Apr 15, 2025

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan

Apr 15, 2025
pulisher
Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Apr 03, 2025
pulisher
Mar 29, 2025

D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - simplywall.st

Mar 28, 2025
pulisher
Mar 28, 2025

When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - Yahoo

Mar 28, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highl - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Decline in Short Interest - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - StreetInsider.com

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Collplant Biotechnologies Q4 2024 misses forecasts - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

CollPlant Biotechnologies Reports 2024 Financial Results - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

CollPlant’s Earnings Call: Mixed Outlook Amid Innovations - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

SEC Form 20-F filed by CollPlant Biotechnologies Ltd - Quantisnow

Mar 26, 2025
pulisher
Mar 26, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings - GuruFocus

Mar 25, 2025
pulisher
Mar 24, 2025

Collplant Biotechnologies Ltd expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 24, 2025

CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday - Defense World

Mar 24, 2025
pulisher
Mar 19, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Quantisnow

Mar 19, 2025
pulisher
Mar 19, 2025

CollPlant to Reveal Full Year 2024 Performance: Key Earnings Call Details Inside - Stock Titan

Mar 19, 2025
pulisher
Mar 18, 2025

Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 18, 2025
pulisher
Mar 05, 2025

Collplant stock hits 52-week low at $3.07 amid market challenges By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Collplant stock hits 52-week low at $3.07 amid market challenges - Investing.com India

Mar 05, 2025
pulisher
Feb 25, 2025

Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Israel-based CollPlant expands distribution for VergenixSTR in Europe and Asia - BSA bureau

Feb 25, 2025
pulisher
Feb 24, 2025

CollPlant expands VergenixSTR distribution in Europe and Asia By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

CollPlant expands European and Asian distribution of soft tissue repair matrix - Yahoo Finance

Feb 24, 2025
pulisher
Feb 24, 2025

CollPlant Expands Vergenix STR Distribution Across Europe And Asia - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Medical Breakthrough: CollPlant's Tendon Treatment Enters 4 New MarketsWhy It Matters - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia - PR Newswire

Feb 24, 2025
pulisher
Feb 12, 2025

CollPlant secures U.S. patent for dermal filler - Investing.com India

Feb 12, 2025
pulisher
Feb 12, 2025

CollPlant secures U.S. patent for dermal filler By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 12, 2025

CollPlant Biotechnologies Provides a Corporate Update - PR Newswire

Feb 12, 2025
pulisher
Feb 10, 2025

Tissue Engineering Market: Key Player Profiles, Industry US$ - openPR

Feb 10, 2025
pulisher
Feb 06, 2025

CollPlant Biotechnologies (NASDAQ:CLGN) Earns Buy Rating from D. Boral Capital - Defense World

Feb 06, 2025
pulisher
Jan 20, 2025

Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World

Jan 20, 2025
pulisher
Jan 09, 2025

US Penny Stocks To Watch In January 2025 - simplywall.st

Jan 09, 2025
pulisher
Dec 01, 2024

CLGN (CollPlant Biotechnologies) 50-Day SMA : $4.31 (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024
pulisher
Nov 30, 2024

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2024 Earnings Call Transcript - MSN

Nov 30, 2024

Collplant Biotechnologies Ltd (CLGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.27
price up icon 1.00%
$71.24
price up icon 2.49%
$32.19
price up icon 0.00%
$27.35
price up icon 8.45%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.27%
자본화:     |  볼륨(24시간):